Non Surgical Periodontal Therapy

2

Review clinical trials related to Non Surgical Periodontal Therapy. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Minimally-Invasive Non-Surgical Therapy of Peri-Implantitis

This multicenter, single-masked randomized controlled clinical trial evaluates the effectiveness of minimally-invasive non-surgical therapy (MINST) compared with standard non-surgical peri-implant therapy (NSPT) in patients diagnosed with peri-implantitis. The study investigates clinical outcomes, radiographic bone levels, patient-reported outcomes, and treatment time over 12 months.

Participants needed: 106
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: St. Anne's University Hospital Brno, Czech RepublicUpdated: Mar 13, 2026Locations: 1
Eligibility criteria

Age ≥18 [+3]

Antibiotics in last 3 months [+7]

Status: Recruiting

Natural Bioactive Gel for Peri-Implantitis

This study is a randomized controlled clinical trial using a split-mouth design to evaluate the effectiveness of a natural bioactive gel (Sterify Gel®) as an adjunct to standard non-surgical therapy for peri-implantitis. Peri-implantitis is an inflammatory disease that affects the tissues around dental implants and can lead to bone loss and implant failure. The goal of the study is to determine whether the application of Sterify Gel®, which contains polyvinyl polymers, hydroxytyrosol, magnesium ascorbyl phosphate, and nisin, can improve clinical outcomes when used in addition to conventional mechanical debridement and air-polishing. The trial will include 20 patients, each with at least two implants in different quadrants affected by peri-implantitis. One implant will be treated with standard therapy plus the gel (test site), while the other will receive standard therapy alone (control site). Clinical outcomes will be measured over a 9-month period, including plaque levels, bleeding on probing, probing depth, suppuration, and bone loss. The results will help assess whether this gel enhances the effectiveness of routine non-surgical peri-implantitis treatment.

Participants needed: 20
Trial details
Age: 18-70Biological sex: AllType: InterventionalSponsor: University of PaviaUpdated: Aug 22, 2025Locations: 1
Eligibility criteria

Patients aged between 18 and 70 years [+6]

Patients with cardiac pacemakers or other implanted electronic devices [+3]